Brokerages Set Solventum Co. (NYSE:SOLV) Price Target at $68.00

Solventum Co. (NYSE:SOLV - Get Free Report) has been assigned a consensus recommendation of "Hold" from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $68.00.

SOLV has been the subject of a number of research analyst reports. BTIG Research initiated coverage on shares of Solventum in a report on Thursday, September 5th. They issued a "neutral" rating for the company. Stifel Nicolaus initiated coverage on Solventum in a research report on Tuesday, October 8th. They issued a "buy" rating and a $82.00 price target for the company. Wells Fargo & Company decreased their price objective on shares of Solventum from $69.00 to $64.00 and set an "equal weight" rating on the stock in a research report on Friday, August 9th. Wolfe Research assumed coverage on shares of Solventum in a report on Thursday, September 26th. They set a "peer perform" rating for the company. Finally, Piper Sandler upped their price target on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a report on Friday, November 8th.

Institutional Trading of Solventum

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Trust & Banking Corp purchased a new stake in shares of Solventum during the 1st quarter valued at about $5,747,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Solventum in the first quarter valued at about $209,000. LRI Investments LLC bought a new position in Solventum during the 1st quarter worth approximately $43,000. Magnetar Financial LLC bought a new position in Solventum during the first quarter worth $3,478,000. Finally, Alpine Global Management LLC acquired a new position in shares of Solventum in the 1st quarter valued at about $1,766,000.

Solventum Stock Up 1.9 %

SOLV traded up $1.31 during trading on Thursday, reaching $69.70. The company's stock had a trading volume of 444,374 shares, compared to its average volume of 1,711,808. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company's fifty day moving average price is $70.49 and its 200-day moving average price is $62.26. Solventum has a 52-week low of $47.16 and a 52-week high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.